The Pharmaceutical Journal
Vol 273 No 7320 p509
9 October 2004

This article
Reprint   Photocopy

  Acrobat Reader

R&D News summary

Vitamin analogue fights cancer

A compound derived from vitamin E reduces the size of tumours in mice, say researchers. They treated mice with a novel non-hydrolysable ether derivative of RRR-a-tocopherol and found that the compound was capable of reducing the primary tumour mass by greater than a half (Experimental Biology and Medicine 2004;229:954).